Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid for pain and stiffness after shoulder arthroscopy and rotator cuff repair
ACTRN12617001074381Phase 4Completed
- Sponsor
- Dr Benjamin Cass
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in rotator cuff tear (2 arms), sponsored by Dr Benjamin Cass. Primary endpoints: Range of motion in the operated shoulder and Postoperative pain. Started Nov 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on ACTRN12617001074381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001074381.